119 related articles for article (PubMed ID: 8210844)
21. Accutane registry compulsory in US, but not Canada.
Andresen M
CMAJ; 2006 Jun; 174(12):1701. PubMed ID: 16754892
[No Abstract] [Full Text] [Related]
22. Mechanism of known environmental teratogens: drugs and chemicals.
Beckman DA; Brent RL
Clin Perinatol; 1986 Sep; 13(3):649-87. PubMed ID: 3533369
[TBL] [Abstract][Full Text] [Related]
23. The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?
Kivelevitch DN; Ryan C; Menter A
J Am Acad Dermatol; 2014 Oct; 71(4):829-31. PubMed ID: 25219705
[No Abstract] [Full Text] [Related]
24. [Drugs and the fetus].
Rise A
Tidsskr Nor Laegeforen; 1976 Jan; 96(1):41-2. PubMed ID: 1257952
[No Abstract] [Full Text] [Related]
25. [Drugs and fetus].
Rise A
Ugeskr Laeger; 1976 Aug; 138(36):2171-2. PubMed ID: 968969
[No Abstract] [Full Text] [Related]
26. [Editorial: Drugs and abnormalities. Background and consequences of warnings].
Naess K
Tidsskr Nor Laegeforen; 1976 Jan; 96(1):47-8. PubMed ID: 1257958
[No Abstract] [Full Text] [Related]
27. [Editorial: Teratogenic agents].
Ferrier PE
Helv Paediatr Acta; 1975 May; 30(1):5-9. PubMed ID: 1158766
[No Abstract] [Full Text] [Related]
28. [Lithium and teratogenicity].
Bjarke B; Rane A; Tomson G
Lakartidningen; 1977 Jul; 74(27-28):2520-1. PubMed ID: 875563
[No Abstract] [Full Text] [Related]
29. Tumor necrosis factor-alfa inhibitors in pregnancy: to prescribe, or not to prescribe, that is the question.
Murase JE; Butler DC
J Am Acad Dermatol; 2014 Oct; 71(4):831-2. PubMed ID: 25219707
[No Abstract] [Full Text] [Related]
30. [Neuroleptics].
Rise A
Tidsskr Nor Laegeforen; 1976 Mar; 96(7):446-7. PubMed ID: 3864
[No Abstract] [Full Text] [Related]
31. A new look at behavioral outcomes and teratogens: a commentary.
Cordero JF
Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):900-2. PubMed ID: 14745925
[No Abstract] [Full Text] [Related]
32. Possible long-term teratogenic effect of isotretinoin in pregnancy.
Malvasi A; Tinelli A; Buia A; De Luca GF
Eur Rev Med Pharmacol Sci; 2009; 13(5):393-6. PubMed ID: 19961047
[TBL] [Abstract][Full Text] [Related]
33. [Local treatment of skin diseases in pregnant women].
Korstanje MJ
Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1609-10. PubMed ID: 7675149
[No Abstract] [Full Text] [Related]
34. [Local treatment of skin diseases in pregnant women].
de Groot AC; Korstanje MJ
Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1609. PubMed ID: 7675148
[No Abstract] [Full Text] [Related]
35. A pox on your practice. iPLEDGE program scars dermatologists.
Ortolon K
Tex Med; 2006 May; 102(5):29-31. PubMed ID: 17115578
[No Abstract] [Full Text] [Related]
36. [Dermatologic therapy in pregnancy].
Wohlrab J
Hautarzt; 2010 Dec; 61(12):1046-51. PubMed ID: 21079902
[TBL] [Abstract][Full Text] [Related]
37. [Drugs in pregnancy and lactation].
Lauritzen C
Zentralbl Gynakol; 1986; 108(3):137-54. PubMed ID: 3962526
[TBL] [Abstract][Full Text] [Related]
38. The effect of cadmium on placental structure and its relation to fetal malformations in the mouse.
Padmanabhan R
Z Mikrosk Anat Forsch; 1986; 100(3):419-27. PubMed ID: 3765785
[No Abstract] [Full Text] [Related]
39. Warfarin embryopathy in siblings.
Harrod MJ; Sherrod PS
Obstet Gynecol; 1981 May; 57(5):673-6. PubMed ID: 7194462
[TBL] [Abstract][Full Text] [Related]
40. [Suspected connection between exposure to hexachlorophene and birth of malformed infants].
Halling H
Lakartidningen; 1977 Feb; 74(7):542-6. PubMed ID: 839891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
